Switzerland Biotechnology & Medical Research

Basilea Pharmaceutica AG (BSLN)

Track

Track

Basilea Pharmaceutica AG experienced nine insider trading transactions over the past ninety days, all representing sales. These divestments totaled approximately 818,906 CHF. This activity follows the August 2026 results financiers, occurring while the stock price reached its fifty-two-week peak after a 32.2% gain during the period.
Ticker: BSLN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Basilea Pharmaceutica AG. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Executive Director / Officer
Transaction date
Sale
Price
447.47
Quantity 1,126
Value CHF741,113
Executive Director / Officer
Transaction date
Sale
Price
134.32
Quantity 2,266
Value CHF1,952,581
Executive Director / Officer
Transaction date
Sale
Price
343.44
Quantity 62,780
Value CHF278,459
Executive Director / Officer
Transaction date
Sale
Price
65.85
Quantity 1,000
Value CHF100,000
Executive Director / Officer
Transaction date
Sale
Price
62.90
Quantity 1,000
Value CHF100,000
Executive Director / Officer
Transaction date
Sale
Price
64.88
Quantity 3,273
Value CHF212,360
Non-Executive Director
Transaction date
Sale
Price
63.96
Quantity 854
Value CHF54,621
Executive Director / Officer
Transaction date
Sale
Price
59.74
Quantity 2,000
Value CHF119,480
Executive Director / Officer
Transaction date
Sale
Price
60.30
Quantity 500
Value CHF30,150
Executive Director / Officer
Transaction date
Sale
Price
52.00
Quantity 400
Value CHF20,800
Executive Director / Officer
Transaction date
Sale
Price
56.20
Quantity 1,043
Value CHF58,617
Executive Director / Officer
Transaction date
Sale
Price
54.00
Quantity 400
Value CHF21,600
Executive Director / Officer
Transaction date
Sale
Price
56.40
Quantity 1,000
Value CHF56,400
Executive Director / Officer
Transaction date
Sale
Price
56.00
Quantity 1,000
Value CHF56,000
Executive Director / Officer
Transaction date
Sale
Price
10.40
Quantity 1,500
Value CHF15,600
Executive Director / Officer
Transaction date
Sale
Price
9.40
Quantity 2,000
Value CHF18,800
Executive Director / Officer
Transaction date
Sale
Price
7.20
Quantity 1,500
Value CHF10,800
Executive Director / Officer
Transaction date
Sale
Price
54.68
Quantity 600
Value CHF32,807
Executive Director / Officer
Transaction date
Sale
Price
48.20
Quantity 600
Value CHF28,920
Executive Director / Officer
Transaction date
Sale
Price
47.00
Quantity 1,200
Value CHF56,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-21 2026-09-21 S Sale Executive Director / Officer
1,126
447.47
CHF741,113 		1,126 447.47 CHF741,113
2026-09-16 2026-09-16 S Sale Executive Director / Officer
2,266
134.32
CHF1,952,581 		2,266 134.32 CHF1,952,581
2026-09-15 2026-09-15 S Sale Executive Director / Officer
62,780
343.44
CHF278,459 		62,780 343.44 CHF278,459
2026-09-11 2026-09-11 S Sale Executive Director / Officer
1,000
65.85
CHF100,000 		1,000 65.85 CHF100,000
2026-09-07 2026-09-07 S Sale Executive Director / Officer
1,000
62.90
CHF100,000 		1,000 62.90 CHF100,000
2026-09-02 2026-09-02 S Sale Executive Director / Officer
3,273
64.88
CHF212,360 		3,273 64.88 CHF212,360
2026-08-21 2026-08-21 S Sale Non-Executive Director
854
63.96
CHF54,621 		854 63.96 CHF54,621
2026-08-19 2026-08-19 S Sale Executive Director / Officer
2,000
59.74
CHF119,480 		2,000 59.74 CHF119,480
2026-08-19 2026-08-19 S Sale Executive Director / Officer
500
60.30
CHF30,150 		500 60.30 CHF30,150
2026-05-29 2026-05-29 S Sale Executive Director / Officer
400
52.00
CHF20,800 		400 52.00 CHF20,800
2026-05-13 2026-05-13 S Sale Executive Director / Officer
1,043
56.20
CHF58,617 		1,043 56.20 CHF58,617
2026-04-30 2026-04-30 S Sale Executive Director / Officer
400
54.00
CHF21,600 		400 54.00 CHF21,600
2026-04-20 2026-04-20 S Sale Executive Director / Officer
1,000
56.40
CHF56,400 		1,000 56.40 CHF56,400
2026-04-17 2026-04-17 S Sale Executive Director / Officer
1,000
56.00
CHF56,000 		1,000 56.00 CHF56,000
2026-04-15 2026-04-15 S Sale Executive Director / Officer
1,500
10.40
CHF15,600 		1,500 10.40 CHF15,600
2026-02-26 2026-02-26 S Sale Executive Director / Officer
2,000
9.40
CHF18,800 		2,000 9.40 CHF18,800
2026-02-24 2026-02-24 S Sale Executive Director / Officer
1,500
7.20
CHF10,800 		1,500 7.20 CHF10,800
2026-02-20 2026-02-20 S Sale Executive Director / Officer
600
54.68
CHF32,807 		600 54.68 CHF32,807
2025-11-24 2025-11-24 S Sale Executive Director / Officer
600
48.20
CHF28,920 		600 48.20 CHF28,920
2025-09-30 2025-09-30 S Sale Executive Director / Officer
1,200
47.00
CHF56,400 		1,200 47.00 CHF56,400
Explore more

More insider trading research around Basilea Pharmaceutica AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index